Kangzhi Pharmaceutical announced that Hainan Hongshi Investment Co., Ltd., the controlling shareholder of the company, has pledged a total of 5 million shares, accounting for 4.94% of its shares and 1.10% of the company's total share capital. The pledger is Huaxia Bank Co., Ltd. Haikou Branch, and the purpose of the pledge is to supplement working capital. As of the disclosure date of the announcement, Hongshi Investment and its co-actors have pledged a total of 102.4 million shares, accounting for 85.00% of the company's shares and 22.50% of the company's total share capital. There is no risk of liquidation and will not lead to a change in the company's actual control.

Kangzhi Pharmaceutical announced that Hainan Hongshi Investment Co., Ltd., the controlling shareholder of the company, has pledged a total of 5 million shares, accounting for 4.94% of its shares and 1.10% of the company's total share capital. The pledger is Huaxia Bank Co., Ltd. Haikou Branch, and the purpose of the pledge is to supplement working capital. As of the disclosure date of the announcement, Hongshi Investment and its co-actors have pledged a total of 102.4 million shares, accounting for 85.00% of the company's shares and 22.50% of the company's total share capital. There is no risk of liquidation and will not lead to a change in the company's actual control.